Counterfeit medicines are a huge problem worldwide, accounting for an estimated 10% of the total market and it’s not just online purchasing where consumers are being affected; even legitimate sources such as pharmacies and hospitals could be at the risk of prescribing drugs that either don’t work or contain dangerous ingredients or harmful impurities.
The EU Falsified Medicines Directive (FMD 2011/62/EU) deadline was recently confirmed for February 2019 while the implementation of the US Drugs Supply Chain Security Act (DSCSA) will happen gradually over the next eight years. The medical device industry also have a number of deadlines to meet between now and 2018 when the Unique Device Identification (UDI) system must be implemented in full on all medical devices. While some big pharmaceutical brands have already started the journey to implement a compliant coding and marking solution, the road is long, and there will be many other manufacturers that are yet to start the process. The Pharma Hub considers all major regulations and will offer advice on topics such as system integration, serialization and new or alternative coding solutions that can address industry challenges. The Pharma Hub will also provide application support and educational documentation such as white papers, customer success stories, application videos and regulatory infographics.
Packaging South Asia is the cooperating media partner for drupa 2016 which is scheduled to be held from 31 May to 10 June at Dusseldorf, Germany.